Stay updated with breaking news from Nasdaq Dbtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Decibel Therapeutics, Inc. (NASDAQ:DBTX – Free Report) were down 7.4% on Wednesday . The stock traded as low as $3.41 and last traded at $3.48. Approximately 54,408 shares traded hands during trading, a decline of 12% from the average daily volume of 62,104 shares. The stock had previously closed at $3.76. Analyst Ratings […]
Decibel Therapeutics, Inc. (NASDAQ:DBTX – Get Rating) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 140,800 shares, a drop of 9.5% from the April 30th total of 155,500 shares. Currently, 1.2% of the company’s shares are sold short. Based […]
Decibel Therapeutics, Inc. (NASDAQ:DBTX – Get Rating) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 140,800 shares, a decrease of 9.5% from the April 30th total of 155,500 shares. Based on an average trading volume of 33,500 shares, the […]
Decibel Therapeutics, Inc. (NASDAQ:DBTX – Get Rating) saw a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 155,500 shares, a decrease of 5.9% from the April 15th total of 165,300 shares. Currently, 1.3% of the shares of the stock are short sold. Based on […]
Several brokerages have updated their recommendations and price targets on shares of Decibel Therapeutics (NASDAQ: DBTX) in the last few weeks: 5/18/2022 – Decibel Therapeutics was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Decibel Therapeutics is a clinical-stage biotechnology company. It engages in discovering […]